Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-02

Clinical Trial Update: Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation [Phase 2]

View source ↗

Summary

Study evaluating how food affects absorption of an oral testosterone undecanoate formulation in men with hypogonadism has completed phase 2 with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone undecanoate (oral) (testosterone undecanoate)

Snippet

Sponsor: Clarus Therapeutics, Inc. | Conditions: Male Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2020-12-02